Steven Feldman is a Dermatology physician affiliated with Wake Forest University School of Medicine. ClinicalTrials.gov lists 11 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4618 Country Club Rd
Winston Salem, NC 271043520
Telephone
336-716-3926Registry record last updated 28 Jul 2015.
Clinical trials
- Opzelura Experience Study
Sponsor: Wake Forest University Health Sciences
- Assessing Psoriasis Treatment Outcomes
Sponsor: Wake Forest University Health Sciences
- Topical Treatment for Atopic Dermatitis
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year2025113 payments$152,967openpaymentsdata.cms.gov ↗
- Janssen Biotech, Inc.Program year202552 payments$104,297openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year202535 payments$54,581openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
40%Interleukin-23 Antagonist12.7%Skyrizi Pen73%Tremfya27%Part D≥30 patientsTNF inhibitor5.6%Humira(Cf) Pen65%Humira Pen35%Part D<11 patients+ 7 more classes in this area
Dermatology
25.6%Corticosteroid11.7%Triamcinolone Acetonide100%Part D≥66 patientsInterleukin-4 Receptor alpha Antagonist5.6%Dupixent Pen100%Part D≥13 patients+ 4 more classes in this area
Sensory organs
16.1%Corticosteroid16.1%Clobetasol Propionate100%Part D≥70 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1998–2010 per NIH RePORTER. The latest:
- Recruiting Rural Parents/Infants to Health Research Projects: Atopic Dermatitis
Wake Forest University Health Sciences
FY2010$185,000R21AI070687 - Recruiting Rural Parents/Infants to Health Research Projects: Atopic Dermatitis
Wake Forest University Health Sciences
FY2009$222,000R21AI070687 - REINFORCING PROPERTIES OF UV LIGHT IN TANNING BED USERS
Wake Forest University Health Sciences
FY2005$847M01RR007122
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Dalane Kitzman, MD
Wake Forest University School of Medicine
Michael Rocco, MD
Wake Forest University School of Medicine
Glenn Lesser, MD
Wake Forest University School of Medicine
Lindsay Strowd, MD
Wake Forest University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”